Refresh

Natco Pharma Ltd. - Research Center

524816 NATCOPHARM Group (A) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20

Sales

1,978.80 1,156.80 1,043.60 724.20 1,011.10

Operating profit

946.00 449.50 50.00 163.00 263.00

Interest

6.20 4.40 8.30 5.00 6.00

Gross profit

979.10 494.50 83.70 210.60 304.10

EPS (Rs)

42.77 18.94 0.56 7.06 10.86
Half yearly  results in details
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20

Other income

39.30 49.40 42.00 52.60 47.10

Stock adjustment

39.50 - 62.80 -68.30 9.70

Raw material

302.70 196.20 293.70 225.50 208.00

Power and fuel

- - - - -

Employee expenses

226.00 236.50 210.20 199.90 194.80

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

464.60 274.60 426.90 204.10 335.60

Provisions made

- - - - -

Depreciation

79.90 75.20 71.10 67.30 56.00

Taxation

133.70 73.60 2.30 14.50 50.50

Net profit / loss

765.50 345.70 10.30 128.80 197.60

Extra ordinary item

- - - - -

Prior year adjustments

- - - - -

Equity capital

35.80 36.50 36.50 36.50 36.40

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

47.81 38.86 4.79 22.51 26.01

GPM (%)

48.52 41.00 7.71 27.11 28.74

NPM (%)

37.93 28.66 0.95 16.58 18.67
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com